These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 34304361)

  • 1. Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors-a review of research and clinical practice.
    Boguszewski MCS; Cardoso-Demartini AA; Boguszewski CL; Chemaitilly W; Higham CE; Johannsson G; Yuen KCJ
    Pituitary; 2021 Oct; 24(5):810-827. PubMed ID: 34304361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement.
    Boguszewski MCS; Boguszewski CL; Chemaitilly W; Cohen LE; Gebauer J; Higham C; Hoffman AR; Polak M; Yuen KCJ; Alos N; Antal Z; Bidlingmaier M; Biller BMK; Brabant G; Choong CSY; Cianfarani S; Clayton PE; Coutant R; Cardoso-Demartini AA; Fernandez A; Grimberg A; Guðmundsson K; Guevara-Aguirre J; Ho KKY; Horikawa R; Isidori AM; Jørgensen JOL; Kamenicky P; Karavitaki N; Kopchick JJ; Lodish M; Luo X; McCormack AI; Meacham L; Melmed S; Mostoufi Moab S; Müller HL; Neggers SJCMM; Aguiar Oliveira MH; Ozono K; Pennisi PA; Popovic V; Radovick S; Savendahl L; Touraine P; van Santen HM; Johannsson G
    Eur J Endocrinol; 2022 Apr; 186(6):P35-P52. PubMed ID: 35319491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 4. Insights from an advisory board: Facilitating transition of care into adulthood in brain cancer survivors with acquired pediatric growth hormone deficiency.
    Alter C; Boguszewski M; Clemmons D; Dobri GA; Geffner ME; Kelepouris N; Miller BS; Oh R; Shea H; Yuen KCJ
    Growth Horm IGF Res; 2024 Feb; 74():101573. PubMed ID: 38368660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety of growth hormone replacement therapy in survivors of cancer and tumors of the pituitary region.
    Bolier M; van der Lelij AJ; Janssens GO; van den Heuvel-Eibrink MM; Neggers SJCMM
    Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk.
    Boguszewski CL
    Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101817. PubMed ID: 37643936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement.
    Darzy KH; Shalet SM
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S30-40. PubMed ID: 16624606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy.
    Gasco V; Caputo M; Cambria V; Beccuti G; Caprino MP; Ghigo E; Maccario M; Grottoli S
    Endocrine; 2019 Feb; 63(2):341-347. PubMed ID: 30341707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GH deficiency in adult survivors of childhood cancer.
    Felicetti F; Fortunati N; Arvat E; Brignardello E
    Best Pract Res Clin Endocrinol Metab; 2016 Dec; 30(6):795-804. PubMed ID: 27974192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy.
    Mukherjee A; Tolhurst-Cleaver S; Ryder WD; Smethurst L; Shalet SM
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1542-9. PubMed ID: 15613427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Safety of Growth Hormone Treatment in Childhood: Two Large Observational Studies: NordiNet IOS and ANSWER.
    Sävendahl L; Polak M; Backeljauw P; Blair JC; Miller BS; Rohrer TR; Hokken-Koelega A; Pietropoli A; Kelepouris N; Ross J
    J Clin Endocrinol Metab; 2021 May; 106(6):1728-1741. PubMed ID: 33571362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study.
    Sklar CA; Mertens AC; Mitby P; Occhiogrosso G; Qin J; Heller G; Yasui Y; Robison LL
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3136-41. PubMed ID: 12107213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH and Childhood-onset Craniopharyngioma: When to Initiate GH Replacement Therapy?
    Nguyen Quoc A; Beccaria K; González Briceño L; Pinto G; Samara-Boustani D; Stoupa A; Beltrand J; Besançon A; Thalassinos C; Puget S; Blauwblomme T; Alapetite C; Bolle S; Doz F; Grill J; Dufour C; Bourdeaut F; Abbou S; Guerrini-Rousseau L; Leruste A; Brabant S; Cavadias I; Viaud M; Boddaert N; Polak M; Kariyawasam D
    J Clin Endocrinol Metab; 2023 Jul; 108(8):1929-1936. PubMed ID: 36794424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?
    Hatrick AG; Boghalo P; Bingham JB; Ayres AB; Sonksen PH; Russell-Jones DL
    Eur J Endocrinol; 2002 Jun; 146(6):807-11. PubMed ID: 12039701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status.
    Toogood AA; Ryder WD; Beardwell CG; Shalet SM
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):97-103. PubMed ID: 7641416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of sellar and suprasellar tumors in children treated with hGH--relation to immunohistochemical study on GH receptor.
    Uchino Y; Saeki N; Iwadate Y; Yasuda T; Konda S; Watanabe T; Wada K; Kazukawa I; Higuchi Y; Iuchi T; Tatsuno I; Yamaura A
    Endocr J; 2000 Mar; 47 Suppl():S33-6. PubMed ID: 10890179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone treatment of children with brain tumors and risk of tumor recurrence.
    Swerdlow AJ; Reddingius RE; Higgins CD; Spoudeas HA; Phipps K; Qiao Z; Ryder WD; Brada M; Hayward RD; Brook CG; Hindmarsh PC; Shalet SM
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4444-9. PubMed ID: 11134091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
    Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
    Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.